advertisement

---

Clinical Therapeutics 2

Showing records 1 to 2 | Display all abstracts in Clinical Therapeutics

20505 Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
Kourlas H; Abrams P
Clinical Therapeutics 2007; 29: 1850-1861

---

20506 A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clinical Therapeutics 2007; 29: 1915-1923

---